| Lastest Insider Transactions Of Akero Therapeutics, Inc. ( AKRO ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-11-25 | Option Exercise | 152,678 | 4.09 | 624,087 | 2025-11-28 06:03:26 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2025-11-24 | Option Exercise | 12,550 | 23.13 | 290,333 | 2025-11-26 16:03:43 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-11-04 | Option Exercise | 8,266 | 24.19 | 199,983 | 2025-11-06 07:00:04 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2025-10-10 | Sell | 30,000 | 53.98 | 1,619,340 | 2025-10-14 20:11:47 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2025-10-10 | Option Exercise | 30,000 | 19.87 | 596,100 | 2025-10-14 20:11:47 |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Directior | 2025-10-08 | Option Exercise | 90,832 | 20.55 | 1,866,155 | 2025-10-10 19:48:05 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-10-07 | Sell | 12,500 | 46.08 | 576,001 | 2025-10-09 18:58:24 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-10-07 | Option Exercise | 12,500 | 28.35 | 354,375 | 2025-10-09 18:58:24 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-10-07 | Sell | 12,500 | 46.08 | 576,001 | 2025-10-09 18:58:24 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-10-07 | Option Exercise | 12,500 | 28.35 | 354,375 | 2025-10-09 18:58:24 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2025-10-08 | Option Exercise | 52,212 | 0.62 | 32,110 | 2025-10-09 18:58:03 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2025-09-11 | Sell | 586 | 43.02 | 25,210 | 2025-09-12 20:39:37 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-09-11 | Sell | 659 | 43.02 | 28,350 | 2025-09-12 20:39:16 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2025-09-11 | Sell | 659 | 43.02 | 28,350 | 2025-09-12 20:38:54 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-09-11 | Sell | 553 | 43.02 | 23,790 | 2025-09-12 20:36:27 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-09-11 | Sell | 553 | 43.02 | 23,790 | 2025-09-12 20:36:27 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2025-09-10 | Sell | 31,796 | 43.23 | 1,374,665 | 2025-09-12 20:36:05 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2025-09-10 | Option Exercise | 14,941 | 8.10 | 121,003 | 2025-09-12 20:36:05 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2025-09-10 | Sell | 31,796 | 43.23 | 1,374,665 | 2025-09-12 20:36:05 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2025-09-10 | Option Exercise | 14,941 | 8.10 | 121,003 | 2025-09-12 20:36:05 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-09-08 | Sell | 12,500 | 44.17 | 552,137 | 2025-09-10 19:48:04 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-09-08 | Option Exercise | 12,500 | 15.18 | 189,766 | 2025-09-10 19:48:04 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2025-09-02 | Sell | 12,500 | 46.08 | 576,035 | 2025-09-04 19:47:35 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2025-09-02 | Sell | 12,500 | 46.08 | 576,035 | 2025-09-04 19:47:35 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2025-09-02 | Option Exercise | 12,500 | 21.10 | 263,750 | 2025-09-04 19:47:35 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2025-09-02 | Option Exercise | 12,500 | 21.10 | 263,750 | 2025-09-04 19:47:35 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2025-09-02 | Sell | 12,500 | 46.08 | 576,035 | 2025-09-04 19:47:35 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2025-09-02 | Option Exercise | 12,500 | 21.10 | 263,750 | 2025-09-04 19:47:35 |
| AKRO | Akero Therapeutics, Inc. | Gangloff Scott A. | Chief Technology Officer | 2025-08-15 | Option Exercise | 2,600 | 19.62 | 51,012 | 2025-08-19 21:32:05 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2025-08-12 | Sell | 12,500 | 47.79 | 597,326 | 2025-08-13 18:37:42 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2025-08-12 | Option Exercise | 12,500 | 21.10 | 263,750 | 2025-08-13 18:37:42 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2025-08-11 | Sell | 30,000 | 48.59 | 1,457,596 | 2025-08-13 18:37:07 |
| AKRO | Akero Therapeutics, Inc. | Henderson Jane | Directior | 2025-08-12 | Sell | 3,000 | 47.46 | 142,371 | 2025-08-12 20:32:47 |
| AKRO | Akero Therapeutics, Inc. | Henderson Jane | Directior | 2025-08-12 | Option Exercise | 3,000 | 7.01 | 21,027 | 2025-08-12 20:32:47 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-08-05 | Sell | 12,500 | 49.30 | 616,299 | 2025-08-07 09:00:04 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-08-05 | Option Exercise | 12,500 | 21.09 | 263,625 | 2025-08-07 09:00:04 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-07-16 | Sell | 10,000 | 52.95 | 529,467 | 2025-07-18 18:00:06 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-07-16 | Option Exercise | 10,000 | 19.87 | 198,700 | 2025-07-18 18:00:06 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-07-16 | Sell | 10,000 | 52.95 | 529,467 | 2025-07-18 18:00:06 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-07-16 | Option Exercise | 10,000 | 19.87 | 198,700 | 2025-07-18 18:00:06 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2025-07-10 | Sell | 30,000 | 51.16 | 1,534,895 | 2025-07-11 18:30:05 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-07-07 | Sell | 12,500 | 51.09 | 638,661 | 2025-07-09 19:00:05 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-07-07 | Option Exercise | 12,500 | 21.09 | 263,625 | 2025-07-09 19:00:05 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2025-07-01 | Sell | 2,000 | 52.88 | 105,760 | 2025-07-03 18:00:07 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2025-06-18 | Sell | 6,620 | 54.84 | 363,041 | 2025-06-20 21:09:06 |
| AKRO | Akero Therapeutics, Inc. | Gangloff Scott A. | Chief Technology Officer | 2025-06-18 | Sell | 848 | 54.84 | 46,504 | 2025-06-20 21:08:53 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2025-06-20 | Sell | 875 | 54.59 | 47,766 | 2025-06-20 21:08:21 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-06-18 | Sell | 1,129 | 54.84 | 61,914 | 2025-06-20 21:07:54 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2025-06-18 | Sell | 1,634 | 54.84 | 89,609 | 2025-06-20 21:07:30 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-06-18 | Sell | 1,633 | 54.84 | 89,554 | 2025-06-20 21:07:12 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2025-06-18 | Sell | 1,453 | 54.84 | 79,683 | 2025-06-20 21:06:51 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-06-16 | Sell | 10,000 | 54.23 | 542,306 | 2025-06-20 09:22:33 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-06-16 | Option Exercise | 10,000 | 21.10 | 211,000 | 2025-06-20 09:22:33 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2025-06-16 | Sell | 2,000 | 54.14 | 108,272 | 2025-06-20 09:22:16 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2025-06-16 | Option Exercise | 2,000 | 19.87 | 39,740 | 2025-06-20 09:22:16 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2025-06-16 | Sell | 2,000 | 54.14 | 108,272 | 2025-06-20 09:22:16 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2025-06-16 | Option Exercise | 2,000 | 19.87 | 39,740 | 2025-06-20 09:22:16 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2025-06-10 | Sell | 37,837 | 54.05 | 2,044,940 | 2025-06-12 18:34:13 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-06-10 | Sell | 2,358 | 54.00 | 127,323 | 2025-06-12 18:33:57 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2025-06-10 | Sell | 2,804 | 53.99 | 151,402 | 2025-06-12 18:33:38 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-06-10 | Sell | 2,803 | 54.00 | 151,351 | 2025-06-12 18:33:19 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2025-06-10 | Sell | 919 | 54.00 | 49,625 | 2025-06-12 18:32:59 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2025-06-10 | Sell | 2,493 | 53.99 | 134,605 | 2025-06-12 18:32:35 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-06-05 | Sell | 37,500 | 54.52 | 2,044,634 | 2025-06-09 17:30:35 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-06-05 | Option Exercise | 37,500 | 21.09 | 791,004 | 2025-06-09 17:30:35 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2025-06-02 | Sell | 4,000 | 50.31 | 201,258 | 2025-06-04 17:36:24 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2025-06-02 | Option Exercise | 4,000 | 19.87 | 79,480 | 2025-06-04 17:36:24 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2025-05-22 | Sell | 4,000 | 50.00 | 200,000 | 2025-05-23 17:30:04 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2025-05-22 | Option Exercise | 4,000 | 44.37 | 177,480 | 2025-05-23 17:30:04 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-05-15 | Sell | 10,000 | 39.30 | 392,978 | 2025-05-19 19:06:47 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-05-15 | Option Exercise | 10,000 | 21.10 | 211,000 | 2025-05-19 19:06:47 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2025-05-12 | Sell | 30,000 | 41.48 | 1,244,455 | 2025-05-13 21:11:49 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2025-05-07 | Sell | 8,000 | 42.49 | 339,950 | 2025-05-09 19:18:09 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2025-05-07 | Option Exercise | 8,000 | 19.87 | 158,960 | 2025-05-09 19:18:09 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-05-06 | Sell | 12,500 | 43.43 | 542,864 | 2025-05-08 19:34:34 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-05-06 | Option Exercise | 12,500 | 21.10 | 263,750 | 2025-05-08 19:34:34 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-04-24 | Sell | 6,250 | 41.03 | 256,438 | 2025-04-28 18:22:04 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-04-24 | Option Exercise | 6,250 | 21.10 | 131,875 | 2025-04-28 18:22:04 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-04-15 | Sell | 9,073 | 37.91 | 343,962 | 2025-04-16 18:00:05 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-04-15 | Option Exercise | 9,073 | 21.10 | 191,440 | 2025-04-16 18:00:05 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2025-04-10 | Sell | 30,000 | 35.23 | 1,056,780 | 2025-04-11 18:00:05 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-04-07 | Sell | 6,250 | 35.88 | 224,262 | 2025-04-10 18:00:04 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-04-07 | Option Exercise | 6,250 | 21.10 | 131,875 | 2025-04-10 18:00:04 |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Directior | 2025-03-25 | Buy | 200,000 | 43.94 | 8,787,921 | 2025-03-27 19:42:13 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-03-17 | Sell | 10,000 | 44.76 | 447,605 | 2025-03-18 17:30:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-03-17 | Option Exercise | 10,000 | 21.10 | 211,000 | 2025-03-18 17:30:17 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2025-03-12 | Sell | 1,738 | 44.88 | 78,001 | 2025-03-14 21:18:12 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2025-03-12 | Sell | 607 | 44.88 | 27,242 | 2025-03-14 20:33:23 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-03-12 | Sell | 614 | 44.88 | 27,556 | 2025-03-14 20:30:03 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2025-03-12 | Sell | 676 | 44.88 | 30,339 | 2025-03-14 20:24:56 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-03-12 | Sell | 516 | 44.88 | 23,158 | 2025-03-14 20:18:50 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2025-03-10 | Sell | 30,000 | 41.77 | 1,253,070 | 2025-03-12 18:00:04 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-03-05 | Sell | 12,500 | 44.53 | 556,590 | 2025-03-07 17:30:05 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-03-05 | Option Exercise | 12,500 | 21.10 | 263,750 | 2025-03-07 17:30:05 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-03-05 | Sell | 12,500 | 44.53 | 556,590 | 2025-03-07 17:30:05 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-03-05 | Option Exercise | 12,500 | 21.10 | 263,750 | 2025-03-07 17:30:05 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2025-03-04 | Sell | 50,000 | 44.86 | 2,243,213 | 2025-03-05 18:56:01 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2025-03-03 | Sell | 1,000 | 48.09 | 48,090 | 2025-03-05 18:55:37 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2025-03-03 | Option Exercise | 1,000 | 19.87 | 19,870 | 2025-03-05 18:55:37 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-02-18 | Sell | 10,000 | 49.87 | 498,660 | 2025-02-21 17:31:02 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-02-18 | Option Exercise | 10,000 | 21.10 | 211,000 | 2025-02-21 17:31:02 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2025-02-10 | Sell | 30,000 | 52.73 | 1,581,994 | 2025-02-11 21:30:58 |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Directior | 2025-01-30 | Buy | 200,000 | 48.00 | 9,600,000 | 2025-02-07 19:54:28 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-02-05 | Sell | 18,750 | 56.51 | 1,059,630 | 2025-02-07 18:05:16 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-02-05 | Option Exercise | 18,750 | 21.10 | 395,625 | 2025-02-07 18:05:16 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2025-02-03 | Sell | 10,000 | 53.81 | 538,061 | 2025-02-05 09:03:18 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-01-27 | Sell | 53,590 | 56.25 | 3,014,217 | 2025-01-31 09:14:58 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-01-27 | Option Exercise | 53,590 | 10.48 | 561,807 | 2025-01-31 09:14:58 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-01-27 | Option Exercise | 49,074 | 21.10 | 1,035,461 | 2025-01-31 09:14:14 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2025-01-27 | Sell | 49,074 | 55.72 | 2,734,213 | 2025-01-31 09:14:14 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-01-27 | Sell | 31,250 | 55.77 | 1,742,958 | 2025-01-29 20:43:54 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2025-01-27 | Option Exercise | 31,250 | 20.51 | 640,942 | 2025-01-29 20:43:54 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2024-12-31 | Sell | 5,000 | 57.03 | 285,150 | 2025-01-29 20:43:28 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2024-12-31 | Option Exercise | 4,000 | 19.87 | 79,480 | 2025-01-29 20:43:28 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2025-01-27 | Sell | 30,000 | 54.90 | 1,646,978 | 2025-01-29 20:43:04 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2025-01-24 | Option Exercise | 43,064 | 6.36 | 274,059 | 2025-01-27 18:08:34 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2025-01-23 | Option Exercise | 50,000 | 0.62 | 30,750 | 2025-01-27 18:07:48 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2025-01-02 | Sell | 10,000 | 28.03 | 280,330 | 2025-01-06 14:08:17 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2024-12-16 | Sell | 1,000 | 29.13 | 29,130 | 2024-12-18 21:03:48 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-12-16 | Sell | 9,074 | 29.11 | 264,117 | 2024-12-18 21:01:22 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-12-16 | Option Exercise | 9,074 | 21.10 | 191,461 | 2024-12-18 21:01:22 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2024-12-16 | Sell | 3,800 | 31.10 | 118,172 | 2024-12-18 20:52:52 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2024-12-16 | Option Exercise | 3,800 | 19.87 | 75,506 | 2024-12-18 20:52:52 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2024-12-10 | Sell | 4,818 | 30.91 | 148,934 | 2024-12-12 20:44:00 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2024-12-10 | Option Exercise | 2,450 | 19.87 | 48,682 | 2024-12-12 20:44:00 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-12-10 | Sell | 2,503 | 30.79 | 77,067 | 2024-12-12 20:38:44 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2024-12-10 | Sell | 925 | 30.79 | 28,481 | 2024-12-12 20:29:23 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-12-10 | Sell | 2,810 | 30.79 | 86,520 | 2024-12-12 20:28:07 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2024-12-10 | Sell | 2,817 | 30.79 | 86,735 | 2024-12-12 20:26:47 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-12-10 | Sell | 7,855 | 30.79 | 241,855 | 2024-12-12 20:24:50 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-12-02 | Sell | 25,000 | 32.09 | 802,250 | 2024-12-04 19:36:36 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-12-02 | Option Exercise | 25,000 | 21.10 | 527,500 | 2024-12-04 19:36:36 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-12-02 | Sell | 10,000 | 32.13 | 321,310 | 2024-12-04 19:34:45 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-11-15 | Sell | 9,061 | 27.73 | 251,274 | 2024-11-19 21:57:20 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-11-15 | Option Exercise | 9,061 | 21.10 | 191,187 | 2024-11-19 21:57:20 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-11-06 | Sell | 10,000 | 35.19 | 351,890 | 2024-11-08 17:06:12 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-11-06 | Option Exercise | 10,000 | 0.62 | 6,150 | 2024-11-08 17:06:12 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-11-01 | Sell | 50,716 | 31.57 | 1,601,252 | 2024-11-05 09:04:36 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-11-01 | Option Exercise | 40,716 | 21.09 | 858,700 | 2024-11-05 09:04:36 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-11-01 | Sell | 108,366 | 31.73 | 3,438,312 | 2024-11-05 09:00:35 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-11-01 | Option Exercise | 108,366 | 21.10 | 2,286,523 | 2024-11-05 09:00:35 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-10-30 | Sell | 20,000 | 32.60 | 651,960 | 2024-11-01 20:59:16 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-10-30 | Option Exercise | 20,000 | 21.10 | 422,000 | 2024-11-01 20:59:16 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-10-16 | Sell | 91,634 | 31.41 | 2,878,038 | 2024-10-18 20:57:33 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-10-16 | Option Exercise | 91,634 | 21.10 | 1,933,477 | 2024-10-18 20:57:33 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-10-14 | Sell | 40,000 | 30.15 | 1,206,080 | 2024-10-16 20:06:46 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-10-14 | Option Exercise | 40,000 | 21.09 | 843,600 | 2024-10-16 20:06:46 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-10-14 | Sell | 20,961 | 30.37 | 636,490 | 2024-10-16 20:06:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-10-14 | Option Exercise | 19,825 | 0.62 | 12,192 | 2024-10-16 20:06:17 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-10-01 | Sell | 10,000 | 28.18 | 281,770 | 2024-10-03 20:09:23 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-09-19 | Sell | 5,500 | 27.65 | 152,086 | 2024-09-23 18:00:05 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-09-19 | Option Exercise | 5,500 | 0.62 | 3,383 | 2024-09-23 18:00:05 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-09-16 | Sell | 8,393 | 27.54 | 231,175 | 2024-09-18 21:19:39 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-09-16 | Option Exercise | 8,393 | 0.62 | 5,162 | 2024-09-18 21:19:39 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-09-13 | Sell | 568 | 26.18 | 14,870 | 2024-09-13 17:16:02 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-09-10 | Sell | 637 | 26.18 | 16,677 | 2024-09-13 17:14:39 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2024-09-10 | Sell | 639 | 26.18 | 16,729 | 2024-09-13 17:13:29 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2024-09-10 | Sell | 537 | 26.18 | 14,059 | 2024-09-13 17:11:41 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-09-10 | Sell | 1,738 | 26.18 | 45,501 | 2024-09-13 17:10:03 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Sell | 14,051 | 27.52 | 386,714 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Sell | 14,051 | 27.52 | 386,714 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Option Exercise | 14,051 | 0.62 | 8,641 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Option Exercise | 14,051 | 0.62 | 8,641 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Sell | 14,051 | 27.52 | 386,714 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Option Exercise | 14,051 | 0.62 | 8,641 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Sell | 14,051 | 27.52 | 386,714 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Option Exercise | 14,051 | 0.62 | 8,641 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Sell | 14,051 | 27.52 | 386,714 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Option Exercise | 14,051 | 0.62 | 8,641 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Sell | 14,051 | 27.52 | 386,714 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Option Exercise | 14,051 | 0.62 | 8,641 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-08-16 | Option Exercise | 24,538 | 0.62 | 15,091 | 2024-08-20 11:45:48 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-08-01 | Sell | 5,000 | 26.75 | 133,756 | 2024-08-02 21:32:18 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-08-01 | Sell | 5,000 | 26.75 | 133,756 | 2024-08-02 21:32:18 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-08-01 | Sell | 5,000 | 26.75 | 133,756 | 2024-08-02 21:32:18 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-08-01 | Sell | 5,000 | 26.75 | 133,756 | 2024-08-02 21:32:18 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-08-01 | Sell | 5,000 | 26.75 | 133,756 | 2024-08-02 21:32:18 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2024-07-23 | Sell | 161,855 | 27.07 | 4,381,867 | 2024-07-25 17:54:02 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2024-07-23 | Option Exercise | 161,855 | 7.01 | 1,134,442 | 2024-07-25 17:54:02 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2024-07-16 | Sell | 34,811 | 28.05 | 976,275 | 2024-07-18 21:41:19 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2024-07-16 | Option Exercise | 29,803 | 7.01 | 208,889 | 2024-07-18 21:41:19 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-06-28 | Sell | 5,000 | 23.40 | 117,020 | 2024-07-02 18:55:16 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-06-11 | Sell | 2,516 | 22.64 | 56,965 | 2024-06-13 18:13:58 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-06-11 | Sell | 2,825 | 22.64 | 63,961 | 2024-06-13 18:11:17 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2024-06-11 | Sell | 2,831 | 22.64 | 64,094 | 2024-06-13 18:09:32 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2024-06-11 | Sell | 2,380 | 22.64 | 53,886 | 2024-06-13 18:06:46 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2024-06-11 | Sell | 569 | 22.64 | 12,883 | 2024-06-13 18:04:29 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-06-11 | Sell | 7,894 | 22.64 | 178,728 | 2024-06-13 18:01:43 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-06-03 | Sell | 5,000 | 19.29 | 96,440 | 2024-06-05 17:05:34 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-05-01 | Sell | 5,000 | 20.15 | 100,750 | 2024-05-02 21:07:17 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-04-01 | Sell | 5,000 | 24.38 | 121,913 | 2024-04-03 18:55:44 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-03-13 | Sell | 723 | 28.33 | 20,483 | 2024-03-15 16:45:03 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2024-03-13 | Sell | 724 | 28.33 | 20,511 | 2024-03-15 16:44:12 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-03-13 | Sell | 1,969 | 28.33 | 55,782 | 2024-03-15 16:43:18 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-03-13 | Sell | 651 | 28.33 | 18,443 | 2024-03-15 16:42:38 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2024-03-13 | Sell | 619 | 28.33 | 17,536 | 2024-03-15 16:42:21 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-03-04 | Sell | 75,000 | 32.87 | 2,465,063 | 2024-03-06 20:14:26 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-03-04 | Option Exercise | 75,000 | 17.17 | 1,288,062 | 2024-03-06 20:14:26 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-03-04 | Sell | 20,646 | 35.49 | 732,727 | 2024-03-06 20:13:26 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-03-04 | Option Exercise | 20,646 | 13.96 | 288,124 | 2024-03-06 20:13:26 |
